Firas R. Muwalla, MD
Hematology & Oncology Physician · Merritt Island, FL
Firas R. Muwalla, MD is a hematology & oncology physician with a practice address in Merritt Island, Florida, and NPI 1013979566, issued on Apr 3, 2006. Check the license (Florida ME94732, as entered in NPPES) on the Florida health license search; the Medicare figures below come from public CMS files.
- Name
- Firas R. Muwalla
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License number
- ME94732 FL
Self-reported in NPPES; status is on the state search - Practice location
- 225 Cone RD, Merritt Island, FL 32952
- Phone
- (321) 453-1361
- Enumerated
- Apr 3, 2006
- Record last updated
- Feb 27, 2020 (not updated in 6 years: call before relying on the address or phone)
- Fax
- (321) 452-4939
- Medicaid ID
- 274921100 FL
- Medicare enrollment
- Enrolled (PECOS I20221013001578); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 818 in Florida → Look up another NPI →
Verify Firas R. Muwalla in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersFlorida health license search
Search for license ME94732Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
38% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
542 Medicare Part D claims for 81 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 44% of claims.
Most prescribed
- Eliquis37 claims
- Xarelto33 claims
- Tamoxifen Citrate31 claims
- Hydroxyurea30 claims
- Anastrozole25 claims
- Brukinsa23 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $761.14
22 payments; by number, the most common kind was food and beverage; the largest payer was Pfizer Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through 2 group practices
- Platte Valley Medical Group LLCBrighton, CO
- Rockford Health PhysiciansRockford, IL
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Firas R. Muwalla among 818 hematology & oncology physician records in Florida
Firas R. Muwalla, MD is one of 818 hematology & oncology physician records with a practice address in Florida. 84% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 21% of them.
- NPI issued2006 · 21% of these records are older, 54% newer
- In a Medicare fileYes · 84% of these records are
- In the CMS Doctors and Clinicians fileYes · 71% of these records are
- Graduated1992 · median 2003 among the 581 with a school on file
- Record last updated2020 · 52% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Florida practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Florida
There are 818 hematology & oncology physician records in Florida.
All 818 in Florida → Every provider in Merritt Island → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Martin Dietrich, M.D., PH.D.Rockledge, FL 329551669790119
- Isaac Esseesse, M.D.Rockledge, FL 329551194820019
- Carl Tahn, M.D.Rockledge, FL 329551508961319
- William McGarry, M.D.Vero Beach, FL 329601760486005
- Moussa Sissoko, MDVero Beach, FL 329601669679809
- Nataly Torrejon Guzman, MDVero Beach, FL 329601548812449
- Simon Vinarsky, MDVero Beach, FL 329601245268838
- Frederick Weeks, M.D.Vero Beach, FL 329601225030471
Common questions
What is Firas R. Muwalla, MD's NPI number?
Firas R. Muwalla, MD's National Provider Identifier (NPI) is 1013979566, issued on Apr 3, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Firas R. Muwalla, MD located?
The NPPES record lists a practice address at 225 Cone RD, Merritt Island, FL, 32952. Phone: (321) 453-1361. Providers update this record themselves, so call before visiting.
How can I verify Firas R. Muwalla, MD's license?
NPPES lists Florida license number ME94732, as entered by the provider. Search the Florida health license search at https://mqa-internet.doh.state.fl.us/mqasearchservices/healthcareproviders. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Firas R. Muwalla, MD prescribe under Medicare Part D?
In 2024, Firas R. Muwalla, MD had 542 Medicare Part D claims for 81 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.